Kazia Therapeutics (KZIA) Receivables - Other (2009 - 2025)

Kazia Therapeutics (KZIA) posted Receivables - Other of $5123.5 for Q2 2025, down 80.32% on a QoQ basis from $26039.6 in Q4 2023.

Kazia Therapeutics (KZIA) Receivables - Other (2009 - 2025) Analysis & Trends

Kazia Therapeutics' Receivables - Other history runs 11 years deep, the most recent figure standing at $5123.5 for Q2 2025.

Quarterly Receivables - Other changed N/A year-over-year to $5123.5 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $5123.5 (changed N/A YoY) and the FY2025 annual result came in at $5123.5, down 2.82% from the prior year.
Receivables - Other was $5123.5 for Q2 2025 at Kazia Therapeutics, down from $26039.6 in the prior quarter.
Across five years, Receivables - Other topped out at $69509.5 in Q2 2023 and bottomed at $5123.5 in Q2 2025.
A 4-year average of $37569.5 and a median of $28650.7 in 2022 frame the typical range for Receivables - Other.
Annual changes were most pronounced in 2022 — Receivables - Other tumbled 51.04% — and 2023, when it soared 142.61%.
Kazia Therapeutics' Receivables - Other stood at $58524.2 in 2021, then tumbled by 51.04% to $28650.7 in 2022, then fell by 9.11% to $26039.6 in 2023, then plunged by 80.32% to $5123.5 in 2025.
Business Quant data shows KZIA's Receivables - Other at $5123.5 in Q2 2025, $26039.6 in Q4 2023, and $69509.5 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Kazia Therapeutics	4.11 Mn	4.11 Mn	-

Download Data